We are live on ! Find out more
AIM

Alambic Investment Management Portfolio holdings

AUM $9.12M
1-Year Est. Return 34.55%
This Fund
S&P 500
This Quarter Est. Return
+15.98%
1 Year Est. Return
+34.55%
3 Year Est. Return
+47.56%
5 Year Est. Return
+107.87%
10 Year Est. Return
AUM
$244M
AUM Growth
+$5.79M
Cap. Flow
-$23.6M
Cap. Flow %
-9.68%
Top 10 Hldgs %
11.14%
Holding
428
New
125
Increased
66
Reduced
150
Closed
85

Sector Composition

Rank Sector Weight
1 Industrials 21.51%
2 Technology 18.54%
3 Consumer Discretionary 17.14%
4 Healthcare 12.6%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKX
151
DELISTED
Skechers
SKX
$582K 0.24%
17,308
-20,713
-54% -$619K
SRGA
152
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$577K 0.24%
3,198
-2,225
-41% -$322K
ACTG icon
153
Acacia Research
ACTG
$457M
$575K 0.24%
176,274
-30,033
-15% -$93.2K
DIN icon
154
Dine Brands
DIN
$455M
$571K 0.23%
6,250
-5,550
-47% -$472K
RBBN icon
155
Ribbon Communications
RBBN
$363M
$570K 0.23%
+110,700
New +$593K
ODC icon
156
Oil-Dri
ODC
$1.26B
$568K 0.23%
36,506
+6,726
+23% +$95.6K
CSII
157
DELISTED
Cardiovascular Systems, Inc.
CSII
$566K 0.23%
14,637
-7,922
-35% -$269K
EGIO
158
DELISTED
Edgio, Inc. Common Stock
EGIO
$562K 0.23%
4,352
-13,382
-75% -$1.55M
ROCC
159
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$551K 0.23%
+12,500
New +$669K
OC icon
160
Owens Corning
OC
$12.5B
$548K 0.22%
+11,620
New +$568K
VECO icon
161
Veeco
VECO
$3.03B
$540K 0.22%
49,774
-251,840
-83% -$2.6M
JYNT icon
162
The Joint Corp
JYNT
$120M
$538K 0.22%
34,176
+15,922
+87% +$168K
CSBR icon
163
Champions Oncology
CSBR
$72.8M
$529K 0.22%
54,067
+26,557
+97% +$265K
VLGEA icon
164
Village Super Market
VLGEA
$617M
$527K 0.22%
19,284
+5,922
+44% +$168K
ZVO
165
DELISTED
Zovio Inc. Common Stock
ZVO
$527K 0.22%
86,258
-128,598
-60% -$1.04M
YARW
166
Yarrow Bioscience, Inc. Common Stock
YARW
$112M
$526K 0.22%
19
-29
-60% -$696K
UFI icon
167
UNIFI
UFI
$132M
$523K 0.21%
27,007
+16,240
+151% +$354K
MLR icon
168
Miller Industries
MLR
$612M
$520K 0.21%
16,870
+429
+3% +$13.3K
PBPB
169
DELISTED
Potbelly
PBPB
$517K 0.21%
60,802
-53,546
-47% -$453K
BRY
170
DELISTED
Berry Corp
BRY
$515K 0.21%
+44,600
New +$507K
SPNE
171
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$513K 0.21%
+34,025
New +$526K
OFIX icon
172
Orthofix Medical
OFIX
$430M
$504K 0.21%
+8,936
New +$502K
STAA icon
173
STAAR Surgical
STAA
$1.25B
$503K 0.21%
14,713
-9,183
-38% -$325K
HNI icon
174
HNI Corp
HNI
$3.61B
$501K 0.21%
+13,800
New +$531K
EQT icon
175
EQT Corp
EQT
$33.9B
$499K 0.2%
+24,050
New +$470K

Similar funds

Alambic Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Alambic Investment Management held 428 positions worth $244M, up 2.4% from $238M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Alambic Investment Management withdrew a net $23.6M in Q1 2019, closing 85 positions and reducing 150 holdings. Its most notable exit was Crocs, an estimated $2.15M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Alambic Investment Management opened a new position in Veradigm Inc. Common Stock worth $3.08M.

  • Alambic Investment Management's largest Q1 2019 buy was Veradigm Inc. Common Stock: 322,600 shares worth $3.08M.
  • Alambic Investment Management added most to Steelcase in Q1 2019, an estimated $3.19M increase.
  • Alambic Investment Management's biggest Q1 2019 reduction was Yellow Corporation Common Stock, cutting an estimated $3.6M.
  • Alambic Investment Management fully exited Crocs in Q1 2019, selling an estimated $2.15M.
  • Alambic Investment Management's ten largest holdings make up 11% of its $244M portfolio in Q1 2019.
  • Alambic Investment Management opened 125 new positions and closed 85 in Q1 2019.
  • Alambic Investment Management's portfolio value rose 2.4% quarter-over-quarter to $244M.

Based on Alambic Investment Management's 13F filing for Q1 2019, filed 9 May 2019.